logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Schizoaffective Disorder

    Medications for Schizoaffective Disorder

    FiltersReset Filters
    4 results

    • clozapine

      (clozapine)
      Mylan Pharmaceuticals Inc.
      Usage: Clozapine tablets are indicated for treating treatment-resistant schizophrenia in severely ill patients not responding to standard antipsychotics. They also reduce the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder at chronic risk for suicide.

    • clozapine

      (CLOZAPINE)
      Aurobindo Pharma Limited
      Usage: Clozapine tablets are indicated for treating treatment-resistant schizophrenia in patients who inadequately respond to other antipsychotics and for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder at chronic risk for suicide.

    • invega sustenna

      (paliperidone palmitate)
      Janssen Pharmaceuticals, Inc.
      Usage: INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of schizophrenia and schizoaffective disorder in adults, both as monotherapy and as an adjunct to mood stabilizers or antidepressants.

    • paliperidone

      (paliperidone)
      Archis Pharma LLC
      Usage: Paliperidone extended-release tablets are indicated for the treatment of schizophrenia and schizoaffective disorder, both as monotherapy and in conjunction with mood stabilizers or antidepressants. Efficacy has been established through multiple clinical trials in adults and adolescents.